TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers tested an MRI-based measure called DunedinPACNI in two midlife cohorts and found that faster estimated brain aging was associated with higher blood-based measures of multisystem aging. The results support a possible link, not a diagnosis or a validated way to predict an individual’s future health from one scan.
Researchers studying two groups of adults in Pittsburgh found that a measure derived from a single structural brain MRI was associated with blood-based indicators of aging across multiple body systems. The study, published in npj Aging, tested whether DunedinPACNI could offer information about physiological aging beyond the brain; it does not show that one scan can diagnose how fast an individual’s body is aging.
The researchers analyzed MRI scans and blood biomarker data from 451 participants in the Adult Health and Behavior study and 295 in the Neurobiology of Adult Health study. Both cohorts included generally healthy adults recruited from communities around Pittsburgh. The team used structural features of the brain to calculate DunedinPACNI, a model intended to estimate the pace of physiological aging.
In both cohorts, participants with faster DunedinPACNI scores tended to have higher composite scores built from blood markers linked to aging in several physiological systems. The study assessed different sets of biomarkers in the two cohorts: eight in one and six in the other, drawn from a recommended panel that includes measures related to inflammation, metabolism, kidney function and cardiovascular health. The researchers reported the associations in both groups, but did not formally compare their size because the cohorts differed in recruitment and methods.
The study also examined 224 Adult Health and Behavior participants who had a second blood biomarker assessment between seven and 15 years after baseline. The supplied report describes this longitudinal analysis but does not provide its result. It is therefore not possible from the reported information to say whether the MRI measure predicted later changes in participants’ biomarker scores.
What the MRI Measure Could Add
Blood tests can capture aspects of health across the body, while structural MRI provides information about the brain. A measure that connects the two could help researchers study whether patterns in midlife brain structure track broader physiological aging. The associations across two cohorts offer evidence that DunedinPACNI may reflect more than chronological age or changes confined to the brain.
But the findings are not evidence that a scan can tell a person their biological age with clinical accuracy. The study reports group-level associations, not a confirmed individual forecast, and it does not establish that using the measure improves care or changes health outcomes. Readers should treat the idea of a single-scan aging test as a research question, not an available screening tool.
Products Worth Considering
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
Garmin Forerunner 935 GPS Running and Multisport Watch, Black
Oral-B iO5 Rechargeable Electric Toothbrush with 5 Cleaning Modes and Travel Case, White
As an affiliate, we earn on qualifying purchases.
How DunedinPACNI Was Tested
DunedinPACNI is an MRI-based measure developed using data from the Dunedin Study. It uses structural features from a brain scan and was designed in relation to earlier changes in 19 measures of physiological health. Earlier research had associated faster scores with socioeconomic disadvantage, chronic disease and mortality, but how well the measure tracked whole-body aging across different populations and biological measures remained uncertain.
In this study, investigators from the University of Pittsburgh worked with researchers at the University of Virginia. They processed MRI scans to extract cortical structure measurements and applied the prediction model. They then compared the resulting scores with standardized blood biomarker composites, adjusting analyses for factors including age and sex. The two cohorts used different MRI scanners, protocols, recruitment periods and eligibility criteria, making replication across both groups relevant while also limiting direct comparison.
The researchers tested whether the association persisted after accounting for three other brain-age measures: brainageR, ENIGMA and DeepBrainNet. They reported that the DunedinPACNI associations were largely consistent after adjustment, although one cross-sectional result in the Adult Health and Behavior cohort weakened and was no longer statistically significant after adjustment for DeepBrainNet. The other measures did not show independent associations with the blood-based aging composites.
“The research examined whether an MRI-based aging marker could offer insights beyond the brain itself.”
— The study authors, as summarized in the News-Medical report
Limits of the Aging Prediction Evidence
The reported cross-sectional results show an association, not that brain structure causes faster aging elsewhere in the body. The information provided does not give the longitudinal analysis result, effect sizes, or enough detail to judge how accurately the measure estimates aging for an individual. It also does not establish a clinical threshold for a “fast” score.
The cohorts were recruited in one US region and differed in imaging and study methods. The authors did not formally compare the association estimates between them. The findings therefore do not settle how well the measure would perform in other populations, in people with existing illnesses, or under routine clinical conditions. It is also unclear whether the measure adds useful prediction beyond existing health assessments or could guide treatment.
Results Needed Before Clinical Use
The key next evidence is the complete longitudinal result for the 224 participants who returned for blood testing, including the size and precision of any association between baseline DunedinPACNI and later biomarker scores after accounting for baseline levels. Further studies would need to test the measure in broader populations and independent settings, and determine whether it predicts health outcomes beyond established risk factors.
Until such evidence is available, DunedinPACNI remains a research measure. The study does not recommend brain MRI screening to assess aging, and it does not show that a single scan can provide a definitive reading of a person’s whole-body aging rate.
Key Questions
Can one brain scan tell how quickly my body is aging?
This study does not establish that. It found an association between an MRI-derived score and blood biomarker composites across groups, but did not validate a scan as an individual diagnostic or forecasting test.
What is DunedinPACNI?
DunedinPACNI is a research measure calculated from structural features in a brain MRI. It was developed to estimate the pace of physiological aging based on links between brain structure and earlier changes in multiple health measures.
How many people were included?
The cross-sectional analysis included 451 participants from the Adult Health and Behavior study and 295 from the Neurobiology of Adult Health study. A subgroup of 224 participants in the first cohort had a later blood biomarker assessment.
Did the study show that the scan predicts future health?
The supplied report does not state the result of the longitudinal analysis, which examined later blood biomarker scores. The reported cross-sectional association alone cannot establish future prediction or clinical benefit.
Source: news-medical.net
